🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 18% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
100 Servings
Other Combinations Product Type
18% Evidence Coverage

Supplement Facts — Evidence Check

Bayberry
75 mg
Red Beet
75 mg
Yellow Dock
75 mg
35 mg
📊 Market median: 300.0mg (159 products)
Median 300.0mg This product: 35mg
Fennel
35 mg
35 mg
📊 Market median: 60.0mg (107 products) 📚 1 studies — no high-quality reviews
This product: 35mg
35 mg
📊 Market median: 250.0mg (337 products) 📚 125 studies (Tier A: 1, B: 41)
This product: 35mg
Wild Yam
35 mg
Blessed Thistle
35 mg
30 mg
📊 Market median: 500.0mg (497 products) 📚 132 studies (Tier A: 0, B: 40)
This product: 30mg
In a special base of the following:

Label Claims — Verification

All Other
All Other (98% of products) Structure/Function (80% of products) Nutrient (6% of products) No Claim (2% of products)

Target Groups

Adult (18 - 50 Years) Dairy Free Sugar Free

Product Information

⚠️ Warnings & Precautions

Keep out of reach of children.

Tamper resistant outer seal – do not use if broken.

🧪 Formulation Notes

Contains no added, starches, salt, sugar wheat, corn, yeast, soy, milk, or preservatives.

Additional Information

Store in cool, dry place.

Manufactured under strict GMP and USP guidelines.

For distribution by health care professionals only.

For nutritional information, call 1-307-358-5066

Product Details

DSLD Entry Date 2021-09-24
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 252286
Data Updated 2026-04-11

Research Evidence

5 Research Sources
29 Avg Quality Score
5 Other
D Taraxacum officinale extract shows antitumor effects on pediatric cancer cells and enhance mistletoe therapy
Other Complementary therapies in medicine 2018
D Taraxacum mongolicum Hand.-Mazz. extract disrupts the interaction between triple-negative breast cancer cells and tumor-associated macrophages by inhibiting RAC2/NF-κB p65/p38 MAPK pathway
Other Journal of ethnopharmacology 2025
D Revealing the metabolic mechanism of dandelion extract against A549 cells using UPLC-QTOF MS
Other Biomedical chromatography : BMC 2022
D Combined dandelion extract and all-trans retinoic acid induces cytotoxicity in human breast cancer cells
Other Scientific reports 2023
D Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways
Other Oncotarget 2016
View all evidence for Dandelion →

Compare Similar Products

View all Dandelion products →